PARIS, May 26 /PRNewswire/ --

- Next Generation Emergency Contraceptive Will First be Launched in UK, Germany and France as Company Expands International Operations

HRA Pharma (http://www.hra-pharma.com), a privately-held, European pharmaceutical company that designs products, devices and supporting services in reproductive health and endocrinology, announced today that ellaOne(R) (ulipristal acetate), its next generation emergency contraceptive, has been granted marketing authorization by the European Commission. The unanimous decision by all member states enables HRA Pharma to begin marketing ellaOne throughout the European Union, making it the only approved product to have been specifically designed and developed for use as an emergency contraceptive.

TORONTO, May 26 /PRNewswire/ --

- Redknee's Airtime Reseller Enables VivaCell-MTS to Provide Voucherless Airtime Top-up for Prepaid Customers

Redknee (TSX: RKN), a leading provider of business-critical software and solutions for communications service providers, today announces that VivaCell-MTS (K-Telecom CJSC), the leading mobile operator in Armenia, has launched Redknee's Airtime Reseller; a service that enables voucherless, airtime top-up for its pre-paid customers. In high-growth markets such as Armenia, voucherless airtime top-up enables operators to provide flexibility to its subscribers and reduce voucher distribution costs.

UPPSALA, Sweden, May 26 /PRNewswire/ -- Beactica AB, the Swedish fragment-based drug discovery company, today announced that it has entered into an agreement with Cubist Pharmaceuticals, Inc. (Lexington, MA; NASDAQ: CBST). Under the agreement, Beactica will use its Sprint(TM) surface plasmon resonance (SPR)-integrated drug discovery platform to target multi-component proteins from pathogenic bacteria of interest to Cubist. Financial terms of the agreement were not disclosed.

We are pleased to be working with Cubist in their quest to develop next-generation anti-bacterials said Beactica CEO, Dr Per Källblad. Cubist has excellent strengths in the area and it is a source of pride to have been selected to help progress one of their discovery programmes.

LONDON, May 26 /PRNewswire/ --

Russia has been looked upon as an unfavourable market for electronics manufacturing by foreign electronics manufacturers in the past. This negative perception has been in spite of the country's cost-competitive advantages as well as its growing domestic market. However, liberalisation coupled with heightened demand from key end-user segments such as consumer electronics is aiding the growth of the electronics manufacturing market in Russia.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )

NORTHBROOK, Illinois, May 26 /PRNewswire/ --

- UL looks to new countries and expanded laboratories

Today, Underwriters Laboratories, a world leader in product safety testing and certification, outlined plans to maintain its position as a preferred partner in the photovoltaic (PV) marketplace by enhancing its capabilities, as well as opening and expanding its facilities dedicated to PV services in markets around the world.

LONDON, May 26 /PRNewswire/ --

- Level 3 Addresses Demand for Content Delivery Network Services in Eastern Europe

Level 3 Communications, Inc. (Nasdaq: LVLT) today announced it provides content delivery network (CDN) services to Internet BillBoard, a Czech Republic-based company. Level 3's CDN technology improves online video and flash content delivery for advertising networks, BillBoard and BB Elements, in Eastern European countries, including the Czech Republic, Poland, Romania, Slovakia and Russia.

HALIFAX, Canada, May 26 /PRNewswire/ -- ImmunoVaccine Technologies Inc. (IVT), a Canadian vaccine development company, announced a research partnership with FIT Biotech, a Finland-based , clinical stage company that develops DNA vaccines. This research will formulate FIT Biotech's GTU(R) MultiHIV DNA plasmid with IVT's DepoVax(TM) vaccine delivery system to advance a therapeutic HIV vaccine.

DepoVax(TM) will act as a vector to deliver FIT Biotech's GTU(R) MultiHIV DNA vaccine and our goal is to develop a more sophisticated and efficient HIV vaccine candidate, commented Dr. Marc Mansour, Vice President RD at IVT.

GAITHERSBURG, Maryland, May 26 /PRNewswire/ --

- At half the cost of a traditional statmux, Patton's IpStatMux(TM) Model 3038 provides immediate or future migration to all-IP networking by transparently transmitting up to eight asynchronous EIA-232/V.24 data-streams over Ethernet/IP and synch-serial composite links

Patton -- the leader in business and carrier-class network access, connectivity, Voice-over-IP and triple-play equipment -- is now shipping the IpStatMux(TM) Model 3038 multiport asynchronous statistical multiplexer for industrial automation networks.

Manufactured at Patton's USA headquarters and priced at half the cost of traditional multiplexers, the IpStatMux(TM) offers RS-232/V.24 device networks a smooth transition to Ethernet/IP.